- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Progestin-Releasing LARCs may Raise BMI in Obese Individuals
Long-acting reversible contraceptive (LARC) methods, including intrauterine devices (IUDs) and subdermal implants, have very low failure rates (less than 1%) which rivals those with sterilization. A recent study suggests that progestin-releasing LARCs increases body mass index (BMI), especially in obese users. The study findings were published in the Journal of Pediatric and Adolescent Gynecology on August 10, 2021.
Previous studies comparing the effect of LARCs and BMI in adults are conflicting. However, the effect of LARCs in BMI among adolescents remain understudied. Therefore, Dr Susan M. Coupey and her team conducted a study to compare BMI changes in adolescents using LARCs, specifically, the etonogestrel subdermal implant (ENG-implant), levonorgestrel intrauterine device (LNG-IUD), and copper IUD (Cu-IUD).
In a single-centre retrospective cohort study, the researchers reviewed electronic health records to identify and follow a cohort of 196 adolescents aged 14-19 years with LARCs inserted from 2010 to 2016. Of the total cohort of adolescents, 51% were underweight/normal, 24% overweight, and 25% obese. 59% of the cohort was Hispanic and 29% Black with a mean BMI of 26.4 ± 7.1 kg/m2. The major outcome assessed was BMI change from LARC insertion to first BMI documented after 6-18 months.
Key findings of the study:
- The baseline BMI documented after LARC insertion was 10.1 ± 3.2 months.
- Upon follow-up, the researchers observed BMI change for the total cohort +0.73 ± 1.8 kg/m2, indicating weight gain.
- They found that the mean BMI change for the ENG-implant + LNG-IUD users (n = 127) was larger than for Cu-IUD users (n = 69) (+0.92 ± 1.9 kg/m2 vs +0.37 ± 1.6 kg/m2).
- Upon two-way analysis of variance, they noted that both initial BMI category and type of LARC had an independent significant main effect on BMI change.
- In a significant interaction effect, they observed that obese adolescents had a larger increase in BMI when they were using a progestin-releasing LARC, either ENG-implant or LNG-IUD, as compared to a Cu-IUD.
The authors concluded, "Adolescents using progestin-releasing LARCs had a larger increase in BMI within 6-18 months after device insertion than those using Cu-IUDs. The disproportionate increase in BMI with progestin-releasing LARCs was primarily contributed by obese users."
For further information:
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751